Profile picture

Doctor Alessandro Candreva

University Hospital Zurich, Zurich (Switzerland)
Membership: ESC Professional Member EAPCI Member
Follow
Biography
Thanks to a pliant mentality and a ready mobility, I enriched my medical training at San Raffaele University (Milan, IT) by visiting fellowships throughout Europe (Thoraxcentrum- Rotterdam, NL; Charité- Berlin, DE). In November 2014 I started the Swiss residency program for cardiology at the University Heart Centre (Zurich, CH). In Switzerland, my passion for clinical research bloomed. While pushing forward my interest for coronary intervention, in Zurich I was involved in several research projects on percutaneous valves (MitraClip, TAVI) and clinical cardiology (HF, ACS, Takotsubo). Moreover, I was part of the pre-clinical development of two novel devices (Cardioband and TriCinch), which have now entered the clinical practice. Together with the machine-learning institute at the ETH, we established the SWISSHEART Network with the aim to apply artificial intelligent in cardiovascular science. We were awarded with the prestigious SPHN/PHRT Grant 2018.
Logo ESC

Contributor content

Microcirculatory resistance after primary percutaneous coronary intervention predicts residual myocardial damage: a post hoc analysis from the CLEVER-ACS trial
Presentation
Microcirculatory resistance after primary percutaneous coronary intervention predicts residual myocardial damage: a post hoc analysis from the CLEVER-ACS trial
Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pressure pullbacks gradients (PPG) index.
Presentation
Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pressure pullbacks gradients (PPG) index.
Machine learning for improving risk stratification after ACS
Presentation
Machine learning for improving risk stratification after ACS

ESC 365 is supported by